About Kodelak neo

SHARE WITH FRIENDS:

Codelak neo

📜 Basic information about the drug.
Contents: 4321`6ewq
One tablet contains:
active substance: butamirate citrate - 50,00 mg;
Excipients: lactose monohydrate (milk sugar) - 241,00 mg, hypromellose (methocel-K4M) - 85,00 mg, talc - 4,00 mg, magnesium stearate - 4,00 mg, colloidal silicon dioxide (aerosil) - 6,00 , 5,00 mg, quimolecular povidone (quimolecular polyvinylpyrrolidone) - 57 mg; shell: white opadray (white II opadray 280000M15) (hypromellose (5,58sP) - 4,86 mg, titanium dioxide - 4,68 mg, polydextrose - 1,26 mg, talc - 0,90 mg, maltodextrin / dextrin - 0,72 , 18,00 mg, glycerin / glycerol - XNUMX mg in the form of a preservative powder) - XNUMX mg.

💧 Active substance (XPN):
butamirate

📝 Trade name of the drug:
Code Neo

🧬 Pharmacological group:
antitussive agent with a central effect.

💊 Dosage form:
film-coated, modified tablets.

🧪 Description:
round-shaped, biconvex convex, white film-coated tablets.

The tablet is white or almost white in cross section.

👉 Application:
Dry cough of various etiologies ("flu", influenza, whooping cough and other cases).

It is used in the preoperative and postoperative period, to suppress cough in surgical interventions and bronchoscopy.

Leave a comment